The YUMAB® platform can be used for the engineering of already existing antibodies that were generated externally. Two in-vitro evolution technologies are available for the optimization of the antibody’s affinity, stability, specificity or selectivity:
- in-vitro evolution by YUlight shuffling
- in-vitro evolution by mutagenesis
Additionally, in-silico analysis can be applied to identify and optimize antibodies with the best developability score.
- in-silico analysis and optimization
Contact
YUMAB GMBH
Science Campus Braunschweig-Süd
Inhoffenstr. 7
38124 Braunschweig – Germany
Email: info@yumab.com
Phone: +49 531 481170-0
YUMAB GmbH
Science Campus Braunschweig-Süd
Inhoffenstr. 7
38124 Braunschweig – Germany
Phone: +49 531 481170-0
Fax: +49-531 481170-17
Newsletter
Want to know what we’re up to? Sign up for the newsletter here.
More Information
